Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Clinicopathological and prognostic value of SIRT6 in patients with solid tumors: a meta-analysis and TCGA data review

Fig. 7

Expression of SIRT6 was significantly different in 11 malignant tumor tissues (red) and paired normal tissues (gray). Bladder Urothelial Carcinoma (BLCA); Breast invasive carcinoma (BRCA); Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC); Cholangiocarcinoma (CHOL); Colon adenocarcinoma (COAD); Esophageal carcinoma (ESCA); glioblastoma multiforme (GBM); Head and Neck squamous cell carcinoma (HNSC); Kidney Chromophobe (KIRC); Thyroid carcinoma (THCA) and Uterine Corpus Endometrial Carcinoma (UCEC)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us